NewBiologix
Series ALausanne, SwitzerlandMay 2023
NewBiologix raised €46M in a Series A round in May 2023. The company is based in Lausanne, Switzerland. Investors in the round: Igor Fish, Nicolas Mermod, Recipharm. Data as of Nov 2026.
Amount raised
€46M
€45,745,654
Native amount
50,000,000 USD
Stage
Series A
series a
Investors
3
Provenance & confidence
High confidenceAmount
50,000,000 USD
ECB-at-date → €46M · rate 1.093 on 2023-05-11
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
May 2023
Round type
series a
Amount (EUR)
€46M
Other rounds
same companyThis is the company's only recorded round.